MSKCC
Memorial Sloan Kettering Cancer Center Portfolio holdings
AUM $24.6M
1-Year Return
10.16%
This Quarter Return
+17.8%
1 Year Return
+10.16%
3 Year Return
-15.77%
5 Year Return
–
10 Year Return
–
AUM
$236M
AUM Growth
–
Cap. Flow
+$236M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Royalty Pharma
RPRX
|
+$178M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$26.6M |
| 3 |
Oric Pharmaceuticals
ORIC
|
+$20.4M |
| 4 |
Y-mAbs Therapeutics
YMAB
|
+$10.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 88.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.2B
| $178M | 75.56% |
+3,565,887
| New | +$178M |
|
|
2
VanEck Gold Miners ETF
GDX
$20.1B
| $26.6M | 11.26% |
+738,500
| New | +$26.6M |
|
|
3
Oric Pharmaceuticals
ORIC
$1.04B
| $20.4M | 8.63% |
+602,272
| New | +$20.4M |
|
|
4
Y-mAbs Therapeutics
YMAB
$391M
| $10.7M | 4.55% |
+216,916
| New | +$10.7M |
|